glp 1 liver enzymes GLP-1 Receptor Agonists in Non-Alcoholic Fatty Disease: Current Evidence and Future Perspectives Semaglutide and Its Potential Hepatoprotective

These blood tests help track the safety and effectiveness of the treatment

Get care developed by in-house experts with decades of clinical excellence

The objective of this study was to compare the efficacy and safety of tirzepatide with titrated insulin degludec in individuals with type 2 diabetes who had inadequate glycemic control despite treatment with metformin alone or in combination with SGLT2 inhibitors.In this phase 3 study, participants aged 18 years or older, with a baseline glycated hemoglobin (HbA1c) of 7.0-10.5%, body mass index of at least 25 kg/m2, stable weight, and no prior insulin treatment, were enrolled across multiple centers in 13 countries

Forest plot highlighting the percent changes from baseline in serum calcitonin levels in tirzepatide versus placebo groups